Manal O. Aljuhani
Al Kharj, 16278, Saudi Arabia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Cerebrospinal Fluid Transforming Growth Factor β Isoforms and Disease Progression in Alzheimer's Disease: Longitudinal Evidence from the ADNI Cohort.
Journal: Neurology international
Published: May 07, 2026
CSF Levels of Baseline VCAM-1 and ICAM-1 Are Associated with Tau Pathology in Patients Demonstrating Cognitive Impairment.
Journal: Neurology international
Published: February 27, 2026
Cerebrospinal fluid levels of tumour necrosis factor-α and its receptors are not associated with disease progression in Alzheimer's disease.
Journal: Frontiers in aging neuroscience
Published: December 17, 2024
Stability of ADC measurements in diffusion MRI: A multicenter phantom study using multi-point b-values.
Journal: Radiography (London, England : 1995)
Published: July 04, 2024
Evaluating clinical meaningfulness of anti-β-amyloid therapies amidst amyloid-related imaging abnormalities concern in Alzheimer's disease.
Journal: Brain communications
Published: June 01, 2024
Inflammation subsequent to mild iron excess differentially alters regional brain iron metabolism, oxidation and neuroinflammation status in mice.
Journal: Frontiers in aging neuroscience
Published: February 28, 2024
Cysteine string protein alpha accumulates with early pre-synaptic dysfunction in Alzheimer's disease.
Journal: Brain communications
Published: November 10, 2021
Low Cerebrospinal Fluid Levels of Melanotransferrin Are Associated With Conversion of Mild Cognitively Impaired Subjects to Alzheimer's Disease.
Journal: Frontiers in neuroscience
Published: October 27, 2018
Showing 1-12 of 12
Last Updated: 09/26/2026